These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 10377795)
1. [SPM analysis on PET and SPECT data]. Fukuyama H Rinsho Shinkeigaku; 1999 Jan; 39(1):36-8. PubMed ID: 10377795 [TBL] [Abstract][Full Text] [Related]
2. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique. Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830 [TBL] [Abstract][Full Text] [Related]
3. Mean regional cerebral blood flow images of normal subjects using technetium-99m-HMPAO by automated image registration. Imran MB; Kawashima R; Sato K; Kinomura S; Ito H; Koyama M; Goto R; Ono S; Yoshioka S; Fukuda H J Nucl Med; 1998 Jan; 39(1):203-7. PubMed ID: 9443762 [TBL] [Abstract][Full Text] [Related]
4. Hypoperfusion in the limbic system and prefrontal cortex in depression: SPECT with anatomic standardization technique. Ito H; Kawashima R; Awata S; Ono S; Sato K; Goto R; Koyama M; Sato M; Fukuda H J Nucl Med; 1996 Mar; 37(3):410-4. PubMed ID: 8772633 [TBL] [Abstract][Full Text] [Related]
5. Assessment of SPM in perfusion brain SPECT studies. A numerical simulation study using bootstrap resampling methods. Pareto D; Aguiar P; Pavía J; Gispert JD; Cot A; Falcón C; Benabarre A; Lomeña F; Vieta E; Ros D IEEE Trans Biomed Eng; 2008 Jul; 55(7):1849-53. PubMed ID: 18595803 [TBL] [Abstract][Full Text] [Related]
6. [PET and SPECT investigations in Alzheimer's disease]. Asenbaum S Radiologe; 2003 Jul; 43(7):521-30. PubMed ID: 12955214 [TBL] [Abstract][Full Text] [Related]
7. SPECT image analysis using statistical parametric mapping: comparison of technetium-99m-HMPAO and technetium-99m-ECD. Patterson JC; Early TS; Martin A; Walker MZ; Russell JM; Villanueva-Meyer H J Nucl Med; 1997 Nov; 38(11):1721-5. PubMed ID: 9374340 [TBL] [Abstract][Full Text] [Related]
8. Brain perfusion SPECT with 99mTc-bicisate: comparison with PET measurement and linearization based on permeability-surface area product model. Yonekura Y; Tsuchida T; Sadato N; Nishizawa S; Iwasaki Y; Mukai T; Konishi J; Shibasaki H J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S58-65. PubMed ID: 8263073 [TBL] [Abstract][Full Text] [Related]
9. Cerebral uptake of 99mTc-bicisate in patients with cerebrovascular disease in comparison with CBF and CMRO2 measured by positron emission tomography. Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Fujita H; Shimosegawa E; Kanno I; Aizawa Y; Nagata K J Cereb Blood Flow Metab; 1994 Jan; 14 Suppl 1():S66-75. PubMed ID: 8263074 [TBL] [Abstract][Full Text] [Related]
10. Experimental performance assessment of SPM for SPECT neuroactivation studies using a subresolution sandwich phantom design. Van Laere KJ; Versijpt J; Koole M; Vandenberghe S; Lahorte P; Lemahieu I; Dierckx RA Neuroimage; 2002 May; 16(1):200-16. PubMed ID: 11969329 [TBL] [Abstract][Full Text] [Related]
11. Comparison of [99mTc]HMPAO SPECT with [18F]fluoromethane PET in cerebrovascular disease. Heiss WD; Herholz K; Podreka I; Neubauer I; Pietrzyk U J Cereb Blood Flow Metab; 1990 Sep; 10(5):687-97. PubMed ID: 2384541 [TBL] [Abstract][Full Text] [Related]
12. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207 [TBL] [Abstract][Full Text] [Related]